Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04WTN
|
|||
| Former ID |
DIB001062
|
|||
| Drug Name |
Oxabact
|
|||
| Synonyms |
IxOC-2; Lyophilized live Oxalobacter formigenes cells (oral, hyperoxaluria), OxThera; Lyophilized live Oxalobacter formigenes cells (oral, hyperoxaluria), Ixion/ Q-Med
Click to Show/Hide
|
|||
| Indication | Hyperoxaluria [ICD-11: 5C51.2] | Phase 3 | [1] | |
| Company |
University of Florida
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03938272) An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria (ePHex-OLE). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.